Posted opportunity — confirm at source
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
National Institutes of Health · PA-27-101
See source for award amount
2029-04-05-00-00-00
Confirm exact timezone in the announcement.Small businesses
Geographic eligibility and all attachment-specific conditions require review of the original announcement.
Eligibility details
Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Matching funds & resources
Source matching-funds field: Required.
Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.
About this opportunity
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
Funding geography: Not specified — review source. A funder’s address does not establish eligibility.
Review original source ↗Funding instrument: Grant. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.
Source fields and evidence
id: 359758
Source ↗ · id
opportunityNumber: PA-27-101
Source ↗ · opportunityNumber
opportunityTitle: NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Source ↗ · opportunityTitle
revision: 6
Source ↗ · revision
agencyDetails: {"code":"NIH","seed":"HHS-NIH11","agencyName":"National Institutes of Health","agencyCode":"HHS-NIH11","topAgencyCode":"HHS"}
Source ↗ · agencyDetails
owningAgencyCode: HHS-NIH11
Source ↗ · owningAgencyCode
cfdas: [{"id":429878,"opportunityId":359758,"cfdaNumber":"93.233","programTitle":"National Center on Sleep Disorders Research"},{"id":429882,"opportunityId":359758,"cfdaNumber":"93.242","programTitle":"Mental Health Research Grants"},{"id":429870,"opportunityId":359758,"cfdaNumber":"93.273","programTitle":"Alcohol Research Programs"},{"id":429887,"opportunityId":359758,"cfdaNumber":"93.307","programTitle":"Minority Health and Health Disparities Research"},{"id":432681,"opportunityId":359758,"cfdaNumber":"93.313","programTitle":"NIH Office of Research on Women's Health"},{"id":432680,"opportunityId":359758,"cfdaNumber":"93.350","programTitle":"National Center for Advancing Translational Sciences"},{"id":432679,"opportunityId":359758,"cfdaNumber":"93.351","programTitle":"Research Infrastructure Programs"},{"id":429879,"opportunityId":359758,"cfdaNumber":"93.393","programTitle":"Cancer Cause and Prevention Research"},{"id":429875,"opportunityId":359758,"cfdaNumber":"93.394","programTitle":"Cancer Detection and Diagnosis Research"},{"id":429885,"opportunityId":359758,"cfdaNumber":"93.395","programTitle":"Cancer Treatment Research"},{"id":429863,"opportunityId":359758,"cfdaNumber":"93.837","programTitle":"Cardiovascular Diseases Research"},{"id":429884,"opportunityId":359758,"cfdaNumber":"93.838","programTitle":"Lung Diseases Research"},{"id":429877,"opportunityId":359758,"cfdaNumber":"93.839","programTitle":"Blood Diseases and Resources Research"},{"id":429873,"opportunityId":359758,"cfdaNumber":"93.840","programTitle":"Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders"},{"id":429881,"opportunityId":359758,"cfdaNumber":"93.847","programTitle":"Diabetes, Digestive, and Kidney Diseases Extramural Research"},{"id":432683,"opportunityId":359758,"cfdaNumber":"93.853","programTitle":"Extramural Research Programs in the Neurosciences and Neurological Disorders"},{"id":432682,"opportunityId":359758,"cfdaNumber":"93.855","programTitle":"Allergy and Infectious Diseases Research"},{"id":432684,"opportunityId":359758,"cfdaNumber":"93.859","programTitle":"Biomedical Research and Research Training"},{"id":429872,"opportunityId":359758,"cfdaNumber":"93.865","programTitle":"Child Health and Human Development Extramural Research"},{"id":429865,"opportunityId":359758,"cfdaNumber":"93.866","programTitle":"Aging Research"},{"id":429883,"opportunityId":359758,"cfdaNumber":"93.867","programTitle":"Vision Research"},{"id":433703,"opportunityId":359758}]
Source ↗ · cfdas
applicantTypes: [{"id":"23","description":"Small businesses"}]
Source ↗ · applicantTypes
applicantEligibilityDesc: Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Source ↗ · applicantEligibilityDesc
fundingInstruments: [{"id":"G","description":"Grant"}]
Source ↗ · fundingInstruments
fundingActivityCategories: [{"id":"HL","description":"Health"}]
Source ↗ · fundingActivityCategories
awardFloor: none
Source ↗ · awardFloor
awardCeiling: none
Source ↗ · awardCeiling
responseDate: Apr 05, 2029 12:00:00 AM EDT
Source ↗ · responseDate
responseDateStr: 2029-04-05-00-00-00
Source ↗ · responseDateStr
costSharing: true
Source ↗ · costSharing
lastUpdatedDate: Jun 01, 2026 12:56:46 PM EDT
Source ↗ · lastUpdatedDate
status: posted
Source ↗ · oppHits[id=359758].oppStatus
Related collections: Health funding opportunities · Funding listings with small-business applicant categories · NIH research funding ·
Build your funding pipeline.
Save opportunities, filter by fit, and export your deadlines with membership.
View plans from $49/month ↗